Cystic fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

Sionna Therapeutics (NASDAQ:SION), a clinical-stage biopharma focused on developing cystic fibrosis therapies, opened well above its initial public offering price on Friday in its first trading ...

When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

DelveInsight's Airway Clearance Devices for Cystic Fibrosis Market Insights report provides the current and forecast market ...

If you receive a denial letter from your insurer, don’t appeal the decision before seeking legal advice, says a leading ...

Sionna Therapeutics hopes to raise $150 million and secure a market capitalization of about $692 million in an initial public ...

Chloe and Caleb have grown up at the Alberta Children’s Hospital. Even though the twins live with different conditions, the hospital continues to be a lifeline for each of them. Chloe was diagnosed ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...